Disseminated Fusarium bloodstream infection in a child with acute myeloid leukemia:A case report

被引:0
作者
Jun-Jie Ning [1 ]
Xue-Mei Li [1 ]
Sheng-Qiu Li [1 ]
机构
[1] Department of PICU, First People’s Hospital of Zigong City
关键词
Fusarium; Liposomal amphotericin B; Voriconazole; Acute myeloid leukemia; Agranulocytosis; Case report;
D O I
暂无
中图分类号
R733.71 [急性白血病];
学科分类号
100214 ;
摘要
BACKGROUND Disseminated Fusarium is rare in healthy children. Children with hematological tumors may have secondary fungal infections, including Fusarium infections, which are due to tumor bone marrow infiltration or prolonged bone marrow suppression after chemotherapy. Because of the lack of typical clinical manifestations and effective antifungal drugs, early diagnosis and treatment of the disease are difficult, and the prognosis is poor.CASE SUMMARY The patient in this case was a 13-year-old female child with rash and fever as the first symptoms. She had the characteristics of the four stages of skin that are typical of Fusarium infection. She was diagnosed with disseminated Fusarium infection through skin biopsy and blood culture and diagnosed with Fusarium solani infection based on the morphological characteristics of the blood culture. After treatment with liposome amphotericin B combined with voriconazole, the child recovered.CONCLUSION This case highlights that for children with secondary agranulocytosis after receiving chemotherapy for hematological malignancies, once typical abnormal skin damage is found, the possibility of Fusarium infection should be considered, and voriconazole alone or in combination with polyenes may be the most effective anti-Fusarium drugs. Amphotericin B, the traditional drug of disseminated Fusarium disease, has a high mortality rate, and it is not recommended to use it alone. Adequate neutrophil counts are essential for the treatment of disseminated Fusarium bloodstream infection.
引用
收藏
页码:6049 / 6055
页数:7
相关论文
共 12 条
[1]   Draft Genome Sequence of a Clinical Isolate of Fusarium fujikuroi Isolated from a Male Patient with Acute Myeloid Leukemia [J].
Urbaniak, Camilla ;
Dadwal, Sanjeet ;
Bagramyan, Karine ;
Venkateswaran, Kasthuri .
GENOME ANNOUNCEMENTS, 2018, 6 (25)
[2]  
Does a triple combination have better activity than double combinations against multiresistant fungi? Experimental in vitro evaluation[J] . Adela Martin-Vicente,Josep Guarro,Javier Capilla.International Journal of Antimicrobial Agents . 2016 (4)
[3]   The Impact of Fusarium Mycotoxins on Human and Animal Host Susceptibility to Infectious Diseases [J].
Antonissen, Gunther ;
Martel, An ;
Pasmans, Frank ;
Ducatelle, Richard ;
Verbrugghe, Elin ;
Vandenbroucke, Virginie ;
Li, Shaoji ;
Haesebrouck, Freddy ;
Van Immerseel, Filip ;
Croubels, Siska .
TOXINS, 2014, 6 (02) :430-452
[4]   Fusarium Infection Report of 26 Cases and Review of 97 Cases From the Literature [J].
Muhammed, Maged ;
Anagnostou, Theodora ;
Desalermos, Athanasios ;
Kourkoumpetis, Themistoklis K. ;
Carneiro, Herman A. ;
Glavis-Bloom, Justin ;
Coleman, Jeffrey J. ;
Mylonakis, Eleftherios .
MEDICINE, 2013, 92 (06) :305-316
[5]   Fusarium Infections in Immunocompromised Patients [J].
Nucci, Marcio ;
Anaissie, Elias .
CLINICAL MICROBIOLOGY REVIEWS, 2007, 20 (04) :695-704
[6]   Treating disseminated fusariosis: amphotericin B, voriconazole or both? [J].
Ho, Dora Y. ;
Lee, Jason D. ;
Rosso, Fernando ;
Montoya, Jose G. .
MYCOSES, 2007, 50 (03) :227-231
[7]   Fusarium infection in hematopoietic stem cell transplant recipients [J].
Nucci, M ;
Marr, KA ;
Queiroz-Telles, F ;
Martins, CA ;
Trabasso, P ;
Costa, S ;
Voltarelli, JC ;
Colombo, AL ;
Imhof, A ;
Pasquini, R ;
Maiolino, A ;
Souza, CA ;
Anaissie, E .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (09) :1237-1242
[8]  
Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management[J] . Nucci Marcio,Anaissie Elias.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America . 2002 (8)
[9]   The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients:: a single institution experience over 10 years [J].
Musa, MO ;
Al Eisa, A ;
Halim, M ;
Sahovic, E ;
Gyger, M ;
Chaudhri, N ;
Al Mohareb, F ;
Seth, P ;
Aslam, M ;
Aljurf, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (03) :544-548
[10]   Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management [J].
Boutati, EI ;
Anaissie, EJ .
BLOOD, 1997, 90 (03) :999-1008